Miss Jennifer Kaitlyn Mellish, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 570 Egg Harbor Rd Ste C4c, Sewell, NJ 08080 Phone: 609-267-9400 |
Allison Nardi Occupational Therapist Medicare: Medicare Enrolled Practice Location: 309 Fries Mill Rd Ste 17, Sewell, NJ 08080 Phone: 877-407-3422 Fax: 877-407-4329 |
Gloucester County Special Services Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1474 Tanyard Road, Sewell, NJ 08080 Phone: 856-415-7530 |
Ms. Dana C Cannon, MS OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 41 Borrelly Blvd, Sewell, NJ 08080 Phone: 856-582-2446 |
Ms. Kelly Marie Hill, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 685 Salina Rd, Sewell, NJ 08080 Phone: 856-468-2500 |
Miss Abbe Dantzig, OT Occupational Therapist - Hand Medicare: Not Enrolled in Medicare Practice Location: 570 Egg Harbor Rd, Suite B2, Sewell, NJ 08080 Phone: 856-256-0051 |
Karen Grund Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 123 Egg Harbor Rd, Building 700, Sewell, NJ 08080 Phone: 410-889-0727 Fax: 410-889-0729 |
Charmaine Luceniada, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2403 Thistledown Ct, Sewell, NJ 08080 Phone: 347-244-3227 |
Elizabeth Fenn, MSOT, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 21 Greenwood Dr, Sewell, NJ 08080 Phone: 856-266-2519 |
Megan Marie Gallagher, OTR/L, CHT Occupational Therapist - Hand Medicare: Medicare Enrolled Practice Location: 570 Egg Harbor Rd, Suite B6, Sewell, NJ 08080 Phone: 856-218-8050 Fax: 856-218-8173 |
Mr. Mitchell Federico, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 26 Timbercrest Dr., Sewell, NJ 08080 Phone: 856-464-2556 |
Jennifer A Frazer Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 243 Hurffville Crosskeys Rd, Sewell, NJ 08080 Phone: 856-286-4247 Fax: 856-286-4269 |
Melanie Christine Gioiosa, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1474 Tanyard Road, Sewell, NJ 08080 Phone: 856-415-7530 |
Kelly Garcia, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1474 Tanyard Road, Sewell, NJ 08080 Phone: 856-415-7530 |
Miss Victoria Lynn Giaquinto, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 45 Hollybrook Dr, Sewell, NJ 08080 Phone: 856-340-0478 |
Pierrette K. Yeo Occupational Therapist Medicare: Medicare Enrolled Practice Location: 570 Egg Harbor Rd, Sewell, NJ 08080 Phone: 856-218-8050 |
John T Flood Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 123 Egg Harbor Rd, Sewell, NJ 08080 Phone: 410-889-0727 Fax: 410-889-0729 |
Mrs. Joan Majella Jones, OTR Occupational Therapist Medicare: Medicare Enrolled Practice Location: 570 Egg Harbor Rd, Suite B-6, Sewell, NJ 08080 Phone: 856-218-8050 |
Christopher Bucci Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 10 Heritage Valley Dr, Sewell, NJ 08080 Phone: 609-670-5760 |
Felice Karetny, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 535 Egg Harbor Rd, Sewell, NJ 08080 Phone: 856-582-2688 |
News Archive
Patients treated for early stage colon cancer fared significantly better if they exercised regularly at the level of an hour's walk six times a week, according to a study to be presented at the annual meeting of the American Society of Clinical Oncology.
With the epidemic of obesity in the United States leading to a greater incidence of diabetes among youth, a new study highlights why Americans cannot afford to ignore this dangerous trend: One in five youth with diabetes has already developed two or more additional risk factors for premature heart disease.
Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, and the Multiple Myeloma Research Consortium announced today the initiation of a Phase II clinical trial of the cyclin-dependent kinase inhibitor, AT7519, to treat patients with relapsed or refractory multiple myeloma, an incurable blood cancer. The trial is designed to investigate both single agent and combination activity of AT7519 with bortezomib (VelcadeĀ®).
Savient Pharmaceuticals, Inc. announced it has priced $200 million aggregate principal amount of 4.75% Convertible Senior Notes due 2018 (the "Notes") pursuant to an automatically effective registration statement filed with the Securities and Exchange Commission on January 31, 2011. In addition, Savient has granted the underwriters an option to purchase up to an additional $30 million aggregate principal amount of Notes, solely to cover over-allotments.
› Verified 5 days ago